Quick Answer
ASP Isotopes Inc. reported R&D Expense of $3.14 million for fiscal year 2024.
ASP Isotopes Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $3.14M | +310.5% |
| 2023 | $764.6K | -40.0% |
| 2022 | $1.27M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.10M | +199.5% | +252.1% |
| June 30, 2025 | $879.9K | +85.9% | -42.5% |
| March 31, 2025 | $1.53M | +611.1% | +47.9% |
| September 30, 2024 | $1.03M | +332.5% | +118.6% |
| June 30, 2024 | $473.3K | +87.2% | +120.0% |
| March 31, 2024 | $215.1K | +3.8% | -10.1% |
| September 30, 2023 | $239.2K | -67.9% | -5.4% |
| June 30, 2023 | $252.9K | +64.9% | +22.0% |
- ASP Isotopes Inc. showed an increase of +310.5% in R&D Expense compared to the prior fiscal year.
- Over the 2022–2024 period, ASP Isotopes Inc.’s r&d expense has grown by 146.5% (from $1.27 million to $3.14 million).
- The most recent figure is from ASP Isotopes Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: